Nearly a decade after the original series ended, “Regular Show” is returning with a brand-new continuation titled “Regular Show: The Lost Tapes.” The revival brings back fan-favorite characters ...

A new study finds the proteins responsible for controlling which genes are expressed in a genome do more than simply turn a gene on or off. Essentially, each type of protein that interacts with a gene ...

What started as a routine walk on Monday along one of Atlanta's busiest trails quickly turned into something out of a movie. Joseph Ragland says he and his friends were heading back from dinner near ...

Mordecai and Rigby are so back. The comedic slackers from Cartoon Network's Emmy-winning animated series "Regular Show" are set to return. "Regular Show: The Lost Tapes" will see the pair back for ...

Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with content, and download exclusive resources. Andy Brinkmeyer shares how engineering ...

EVERGLADES, FLA. (WSVN) — A pair of python hunters stumbled across a python swim party that might offer new insights into their nesting patterns in Florida. Professional python hunters Guillermo ...

Pattern made its debut on the Nasdaq after raising $300 million for the company and its investors in an IPO. The Utah-based company is one of the top sellers on Amazon's third-party marketplace. "No ...

Using genomic and transcriptional data has greatly improved the understanding of multiple aspects of human physiology. A new paper in PNAS reports on molecular-level associations of co-occurring ...

Daily sleep and activity are fundamental to both physical and mental health. Although previous studies have largely emphasized quantitative aspects such as sleep duration and physical activity time, ...

Researchers at the Yale School of Public Health have discovered the evolutionary rhythm of gene expression, showing that changes happen at strikingly varied rates. In the study, published in Molecular ...

KEYNOTE-859: 4.5-year median follow-up of pembrolizumab plus chemotherapy for previously untreated advanced HER2-negative gastric or gastroesophageal junction (G/GEJ) adenocarcinoma. This is an ASCO ...